Michelle C Manvell
Imperial College London(GB)
Publications by Year
Research Areas
Cystic Fibrosis Research Advances, Neonatal Respiratory Health Research, Virus-based gene therapy research, RNA Interference and Gene Delivery, CAR-T cell therapy research
Most-Cited Works
- → Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial(2015)420 cited
- → Characterisation of LMD virus-like nanoparticles self-assembled from cationic liposomes, adenovirus core peptide μ (mu) and plasmid DNA(2002)78 cited
- → A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis(2016)45 cited
- → Limitations of the Murine Nose in the Development of Nonviral Airway Gene Transfer(2009)19 cited
- → An immunocytochemical assay to detect human CFTR expression following gene transfer(2009)13 cited
- → Physico-chemical analysis of cationic liposome–DNA complexes (lipoplexes) with respect to in vitro and in vivo gene delivery efficiency†(2001)4 cited
- Safety and adverse events(2016)
- Results of a Phase IIb non-viral gene therapy trial from the UK CF Gene Therapy Consortium(2014)
- Patient information sheets(2016)
- Assessment of immune responses to single and repeat dose aeroslisation of the non-viral formualtion PGM169/GL67A in cystic fibrosis patients(2014)